STOCK TITAN

MiniMed Group (MMED) SVP receives multiple new RSU grants

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

MiniMed Group, Inc. senior vice president and chief HR officer Gillian Chandrasena reported two equity compensation grants of common stock on July 1, 2026. Both transactions are coded as awards, not open‑market purchases or sales.

The filing shows one grant of 14,705 restricted stock units (RSUs) under the 2026 Long Term Incentive Plan that vest in approximately equal one‑third increments on the first, second and third anniversaries of the grant date. A second RSU grant of 29,483 shares vests on the third anniversary of the grant date. Following these awards, reported direct holdings include common stock and shares that will be issued as RSUs vest, as well as 891 shares acquired under the 2026 Employee Stock Purchase Plan on June 30, 2026.

Positive

  • None.

Negative

  • None.
Insider Chandrasena Gillian
Role SVP, Chief HR Officer
Type Security Shares Price Value
Grant/Award Common Stock 29,483 $0.00 --
Grant/Award Common Stock 14,705 $0.00 --
Holdings After Transaction: Common Stock — 160,139 shares (Direct, null)
Footnotes (1)
  1. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date. Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Includes 891 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the third anniversary of the grant date.
RSU grant 1 14,705 shares RSUs vest one-third annually over three years from July 1, 2026
RSU grant 2 29,483 shares RSUs vest on the third anniversary of the July 1, 2026 grant date
Holdings after transaction (line 1) 174,844 shares Direct common stock holdings including shares issuable upon RSU vesting
Holdings after transaction (line 2) 160,139 shares Alternate post-transaction holdings figure from second award row
ESPP acquisition 891 shares Shares acquired under 2026 Employee Stock Purchase Plan on June 30, 2026
restricted stock units ("RSUs") financial
"Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
2026 MiniMed Group, Inc. Long Term Incentive Plan financial
"pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments"
Employee Stock Purchase Plan financial
"Includes 891 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026."
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transactions did MiniMed Group (MMED) report for Gillian Chandrasena?

MiniMed reported two equity awards to SVP and Chief HR Officer Gillian Chandrasena. She received restricted stock unit grants of 14,705 and 29,483 shares as compensation, rather than buying or selling shares on the open market.

Were the MiniMed (MMED) insider transactions open-market buys or sells?

The transactions were compensation awards, not market trades. Both are coded as grants of restricted stock units, meaning the shares are provided by the company under incentive plans instead of being purchased or sold on the stock market.

How do the new MiniMed (MMED) RSU grants to the SVP vest over time?

One RSU grant of 14,705 shares vests in roughly equal one-third portions on the first, second and third anniversaries of the grant date. The separate grant of 29,483 RSUs vests entirely on the third anniversary, creating a longer-term retention incentive.

What equity plans are involved in the MiniMed (MMED) Form 4 filing?

The filing references MiniMed’s 2026 Long Term Incentive Plan, under which RSU grants were awarded, and the 2026 Employee Stock Purchase Plan, through which 891 shares of common stock were acquired on June 30, 2026 by the reporting executive.

How many MiniMed (MMED) shares does the executive hold after the reported grants?

After the reported RSU awards, the filing shows direct ownership line items including 174,844 and 160,139 common shares in separate rows. These amounts include shares that will be issued as restricted stock units vest over time, plus 891 shares from the employee purchase plan.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chandrasena Gillian

(Last)(First)(Middle)
C/O MINIMED GROUP, INC.
18000 DEVONSHIRE STREET

(Street)
NORTHRIDGE CALIFORNIA 91325

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SVP, Chief HR Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock07/01/2026A29,483(1)A$0160,139(2)(3)D
Common Stock07/01/2026A14,705(4)A$0174,844(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date.
2. Includes shares of common stock to be issued in connection with the vesting of one or more RSUs.
3. Includes 891 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026.
4. Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the third anniversary of the grant date.
Remarks:
/s/ Bryan F. Kelly, attorney-in-fact07/06/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)